Fatemeh Sadat Heydari. (2023). Cost-utility Analysis of Dornase alfa in comparison with Tobramycin for Managing Iranian Patients with Cystic Fibrosis. Tehran University of Medical Sciences.
Chicago Style (17th ed.) CitationFatemeh Sadat Heydari. Cost-utility Analysis of Dornase Alfa in Comparison with Tobramycin for Managing Iranian Patients with Cystic Fibrosis. Tehran University of Medical Sciences, 2023.
MLA (9th ed.) CitationFatemeh Sadat Heydari. Cost-utility Analysis of Dornase Alfa in Comparison with Tobramycin for Managing Iranian Patients with Cystic Fibrosis. Tehran University of Medical Sciences, 2023.
Warning: These citations may not always be 100% accurate.